Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: if the true value of the settlement

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

SGE1

Rank: President [?]

Points: 26670 [?]

Votes: 187 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: if the true value of the settlement - Roseny1

in response to

Re: if the true value of the settlement - Emty

rosesny1

posted on Mar 11, 2008 06:47AM

I would think that if customary royalty payments (based on future sales of infringing product) were to be forthcoming, the disclosure would be simply that and nothing more - "ongoing royalty payments will be forthcoming based on future sales of infringing product by certain entites/a certain entity".

Saying more would not only likely violate the CC, but would also not be in PTSC/TPL's best interest, as it would reveal details (e.g., royalty amount per infringing unit sold) that could adversely affect future negotiations.